First Time Loading...

Edesa Biotech Inc
NASDAQ:EDSA

Watchlist Manager
Edesa Biotech Inc Logo
Edesa Biotech Inc
NASDAQ:EDSA
Watchlist
Price: 4.55 USD 0.66% Market Closed
Updated: May 18, 2024

Edesa Biotech Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Edesa Biotech Inc
Selling, General & Administrative Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Edesa Biotech Inc
NASDAQ:EDSA
Selling, General & Administrative
-$4.6m
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Zymeworks Inc
NYSE:ZYME
Selling, General & Administrative
-$70.4m
CAGR 3-Years
-7%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Selling, General & Administrative
-$33.6m
CAGR 3-Years
-36%
CAGR 5-Years
-63%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Selling, General & Administrative
-$31.2m
CAGR 3-Years
-15%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Selling, General & Administrative
-$192.6m
CAGR 3-Years
-16%
CAGR 5-Years
-69%
CAGR 10-Years
-47%
Spectral Medical Inc
TSX:EDT
Selling, General & Administrative
-CA$11.9m
CAGR 3-Years
-6%
CAGR 5-Years
-19%
CAGR 10-Years
0%

See Also

What is Edesa Biotech Inc's Selling, General & Administrative?
Selling, General & Administrative
-4.6m USD

Based on the financial report for Dec 31, 2023, Edesa Biotech Inc's Selling, General & Administrative amounts to -4.6m USD.

What is Edesa Biotech Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-5%

Over the last year, the Selling, General & Administrative growth was 5%. The average annual Selling, General & Administrative growth rates for Edesa Biotech Inc have been -5% over the past three years , -9% over the past five years , and -5% over the past ten years .